Takeda Pharmaceutical Co Ltd
TSE:4502
Takeda Pharmaceutical Co Ltd
TSE:4502
Price:
4 125 JPY
-0.43%
Market Closed
Updated:
May 6, 2024
Takeda Pharmaceutical Co Ltd
Operating Expenses
|
Takeda Pharmaceutical Co Ltd
Operating Expenses Peer Comparison
Comparables:
4568
4578
4523
4519
4503
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Operating Expenses
-¥2.4T
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-8%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Operating Expenses
-¥898.7B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-5%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Operating Expenses
-¥1.1T
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-4%
|
|
|
Eisai Co Ltd
TSE:4523
|
Operating Expenses
-¥525.7B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-5%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Operating Expenses
-¥253.8B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-5%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Operating Expenses
-¥1.4T
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-8%
|
See Also
What is Takeda Pharmaceutical Co Ltd's Operating Expenses?
Operating Expenses
-2.4T
JPY
-2.4T
JPY
Based on the financial report for Dec 31, 2023, Takeda Pharmaceutical Co Ltd's Operating Expenses amounts to -2.4T JPY.
What is Takeda Pharmaceutical Co Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-8%
-8%
Over the last year, the Operating Expenses growth was -4%. The average annual Operating Expenses growth rates for Takeda Pharmaceutical Co Ltd have been -9% over the past three years , -16% over the past five years , and -8% over the past ten years .
You don't have any saved screeners yet
